Dar Dowlatshahi Selected Research

Activities of Daily Living (ADL)

12/2023	Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.
10/2020	Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery, and Community Participation following Stroke. Part One: Rehabilitation and Recovery Following Stroke; 6th Edition Update 2019.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dar Dowlatshahi Research Topics

Disease

76	Stroke (Strokes) 05/2024 - 11/2006
32	Ischemic Stroke 05/2024 - 01/2013
27	Cerebral Hemorrhage 01/2024 - 06/2012
18	Hemorrhage 12/2023 - 06/2012
15	Hematoma 12/2023 - 05/2009
8	Atrial Fibrillation 12/2023 - 09/2013
7	Thrombosis (Thrombus) 01/2022 - 01/2018
6	Transient Ischemic Attack 09/2023 - 11/2010
6	Infarction (Infarctions) 01/2023 - 03/2016
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 07/2012
4	Pain (Aches) 01/2021 - 01/2016
3	Carotid Stenosis (Carotid Artery Stenosis) 12/2023 - 11/2019
3	Venous Thromboembolism 11/2023 - 11/2018
3	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 04/2019
3	Hypertension (High Blood Pressure) 01/2022 - 11/2006
2	Neoplasms (Cancer) 01/2024 - 11/2022
2	Cognitive Dysfunction 12/2023 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 01/2023
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2022 - 11/2018
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2018
2	Coma (Comas) 01/2022 - 12/2015
2	Intracranial Thrombosis (Cerebral Thrombosis) 03/2020 - 11/2018
1	Frailty 01/2024
1	Body Weight (Weight, Body) 01/2024
1	Frontotemporal Dementia (Semantic Dementia) 12/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2023
1	Parkinson Disease (Parkinson's Disease) 12/2023
1	Alzheimer Disease (Alzheimer's Disease) 12/2023
1	ST Elevation Myocardial Infarction 11/2023
1	Arteritis 11/2023
1	Inflammation (Inflammations) 11/2023
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Infections 11/2023
1	Acute Coronary Syndrome 11/2023
1	COVID-19 09/2023
1	Atrophy 01/2023
1	Cerebral Small Vessel Diseases 01/2023
1	Embolic Stroke 01/2022
1	Hemorrhagic Stroke 01/2022
1	Hypertriglyceridemia 01/2022

Drug/Important Bio-Agent (IBA)

25	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024 - 06/2013
21	AnticoagulantsIBA 12/2023 - 07/2012
10	Tenecteplase FDA Link 01/2024 - 03/2015
10	Hemostatics (Antihemorrhagics)IBA 12/2023 - 07/2012
7	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 11/2010
6	TabletsIBA 01/2023 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2018
5	recombinant FVIIa (rFVIIa)FDA Link 12/2023 - 12/2019
4	Antihypertensive Agents (Antihypertensives)IBA 09/2023 - 01/2020
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2023 - 01/2020
4	Vitamin K FDA Link 04/2019 - 11/2015
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023 - 03/2015
3	RivaroxabanIBA 11/2023 - 09/2013
3	Clopidogrel (Plavix)FDA Link 09/2023 - 01/2021
3	TicagrelorIBA 09/2023 - 01/2021
3	prothrombin complex concentrates (PPSB)IBA 07/2023 - 01/2017
3	Dabigatran FDA Link 01/2020 - 09/2013
2	C-Reactive ProteinIBA 11/2023 - 05/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 05/2021
2	Factor VIIa (Activated Factor VII)IBA 01/2023 - 01/2022
2	N 30IBA 01/2023 - 05/2018
2	CDTA (DCTA)IBA 11/2020 - 01/2020
2	apixabanIBA 04/2019 - 09/2013
2	N(4)-oleylcytosine arabinosideIBA 11/2018 - 05/2017
2	FibrinIBA 03/2015 - 01/2014
1	Dihydrotachysterol (AT 10)IBA 01/2024
1	Glial Fibrillary Acidic ProteinIBA 12/2023
1	Amyloid beta-PeptidesIBA 12/2023
1	Colchicine FDA LinkGeneric 11/2023
1	Cytochrome P-450 CYP2C19IBA 09/2023
1	Thrombin FDA Link 07/2023
1	Factor Xa InhibitorsIBA 07/2023
1	Apolipoprotein E4IBA 07/2023
1	SolutionsIBA 02/2023
1	OxylipinsIBA 01/2023
1	Linoleic Acid (Linoleate)IBA 01/2023
1	Epoxide HydrolasesIBA 01/2023
1	Epoxy Compounds (Epoxides)IBA 01/2023
1	AcidsIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Protons (Proton)IBA 01/2022
1	Heparinoids (Heparinoid)IBA 01/2022

Therapy/Procedure

40	Therapeutics 05/2024 - 01/2013
13	Thrombectomy 05/2024 - 06/2016
6	Secondary Prevention 01/2023 - 11/2006
5	Stents 10/2018 - 09/2014
3	Length of Stay 01/2024 - 01/2020
3	Carotid Endarterectomy 12/2023 - 09/2016
3	Stroke Rehabilitation 01/2019 - 01/2016
2	Punctures 01/2024 - 06/2016
2	Activities of Daily Living (ADL) 12/2023 - 10/2020
2	Anticoagulation Reversal 12/2023 - 07/2012
2	Language Therapy (Language Training) 01/2023 - 01/2016
2	Continuity of Patient Care 01/2021 - 01/2020
2	Endarterectomy (Thromboendarterectomy) 01/2021 - 11/2019
1	Critical Care (Surgical Intensive Care) 09/2023
1	Mechanical Ventilators (Ventilator) 09/2023
1	Telerehabilitation 01/2023